Capital International Investors Arrowhead Pharmaceuticals, Inc. Transaction History
Capital International Investors
- $511 Billion
- Q4 2024
A detailed history of Capital International Investors transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital International Investors holds 126,230 shares of ARWR stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
126,230
Previous 255,871
50.67%
Holding current value
$1.95 Million
Previous $4.95 Million
52.09%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARWR
# of Institutions
304Shares Held
95.9MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$243 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$188 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$172 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$93.1 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$80.9 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.64B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...